Kymera Therapeutics Claimed Company

Kymera Therapeutics is a clinical stage biopharmaceutical company pioneering a transformative new modality, “targeted protein degradation” (TPD), with the ability to pursue targets long considered undruggable and to treat disease in entirely new ways. Our team has developed a proprietary drug discovery engine, Pegasus, to enable the design of highly selective, small molecule protein degraders with potent activity against a broad range of disease indications. We are committed to selecting targets with the broadest possible impact across multiple disease indications with high unmet medical need to realize the full potential of TPD. Kymera is led by an expert team of dedicated scientists and drug hunters, with decades of experience in the foundational areas of targeted protein degradation and drug development. read more

EMPLOYEE PARTICIPANTS: 12

TOTAL RATINGS: 194

CEO: Nello Mainolfi, PhD

...

HR or Marketing? Claim Your Free Employer Account

Kymera Therapeutics Office Vibe

Based on 49 ratings about their team and environment, employees at Kymera Therapeutics are satisfied with their office vibe and rank their overall culture within the Top 50% of similar sized companies on Comparably.

Comparably recognizes both team members and the environment curated by the employers as essential to a great office vibe, and has therefore decided to display related data to these two subculture categories.

63% of Kymera Therapeutics' employees look forward to interacting with their coworkers on a daily basis, and 100% say they hang out with their coworkers outside of work Once a quarter. The majority of Kymera Therapeutics employees work on average 8 hours per day in a positive work environment.

Most employees feel Secure Enough about their position at Kymera Therapeutics, and would recommend working there to a friend.

Office Vibe

N/A

Environment

Top 40%Top 40% of Similar Size Companies on Comparably

B-

Kymera Therapeutics is in the Top 40% of Similar Size Companies on Comparably

Team

Bottom 25%Bottom 25% of Similar Size Companies on Comparably

D+

Kymera Therapeutics is in the Bottom 25% of Similar Size Companies on Comparably